ETV + ADV | TDF | TDF + ETV | |
---|---|---|---|
Patient number | 25 | 27 | 20 |
HCC | 1 | 0 | 0 |
Cirrhosis | 0 | 0 | 0 |
Deaths | 0 | 0 | 0 |
ALT flare | 0 | 0 | 0 |
Discontinuation due to adverse event | 2 | 1 | 1 |
baseline eGFR | 125.82 | 122.75 | 127.71 |
eGFR at 48 weeks | 103.76 | 112.32 | 110.26 |
eGFR decline from baseline | 22.06 | 10.43 | 17.45 |
eGFR < 90 mL/min/1.73 m2 at 48 weeks, n(%) | 3, 12.00% | 1, 3.70% | 3, 15.00% |